The Impact of Dexmedetomidine Infusion in Sparing Morphine Consumption in Off-Pump Coronary Artery Bypass Grafting
Conclusion. Our study showed that dexmedetomidine might be an effective adjuvant in reducing both total hospital and intensive care unit length of stay in patients undergoing OPCAB. Dexmedetomidine might play a role in reducing total morphine and fentanyl consumption in OPCAB.
Source: Seminars in Cardiothoracic and Vascular Anesthesia - Category: Anesthesiology Authors: Khalil, M. A., Abdel Azeem, M. S. Tags: Original Research Source Type: research
More News: Anesthesia | Anesthesiology | Cardiology | Coronary Artery Bypass Graft | Fentanyl | Heart | Intensive Care | Morphine | Pediatrics | Study